Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 23, 2013
CAMO Software, leaders in multivariate data analysis solutions, today announced the release of a new version of the Unscrambler® X Process Pulse software for process monitoring. The software is designed to be used by laboratory staff, technical ...
read more
Wednesday, January 23, 2013
Alan Burns, Vice President of Quality Management at pharma and biotech supplier Sartorius Stedium Biotech, has been elected to the Board of Directors of Rx-360. This is an international pharmaceutical supply chain consortium.
read more
Metrics Inc. has named Dr. Thomas B. “Brad” Gold vice president of pharmaceutical development.
The promotion expands Gold’s previous role as senior director of pharmaceutical development and new technology. Capabilities Gold will manage in his new ...
read more
AAIPharma Services Corp. (“AAIPharma”), a leading provider of pharmaceutical product development services, announced today that it has appointed James Fife as the company’s senior director of parenteral operations for its manufacturing facility in ...
read more
Wednesday, January 30, 2013
Leading events organiser, UBM Live, announced today that CPhI Southeast Asia, the first in its annual portfolio of global pharmaceutical ingredients events for 2013, will return this March 20-22 to the Jakarta International Expo in Indonesia. With ...
read more
Wednesday, January 30, 2013
Marken today announced the expansion of its internal regulatory and technical expertise with the promotion of Dan Bell to Vice President. The announcement follows an industry-led panel discussion hosted by Marken in Farmingdale, New York on January ...
read more
Friday, February 01, 2013
Metrics Inc. has appointed Joe Cascone as senior director of operations.
In his new role at Metrics, Cascone will manage the company’s commercial drug product manufacturing and packaging capabilities. He also is responsible for facility-related ...
read more
Friday, February 01, 2013
Patheon Inc., a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced plans for additional investment in its Milton Park facility. Located in Oxfordshire, UK, Milton ...
read more
Tuesday, February 05, 2013
Pharmatek, a premier contract development and manufacturing organization supporting the pharmaceutical industry, announced that it has purchased another Xcelodose® 600S system. This acquisition doubles the company's manufacturing production rate for ...
read more
Tuesday, February 05, 2013
ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has agreed, subject to certain closing conditions, to acquire the Clinical Trial Services ...
read more
Thursday, February 07, 2013
The Scientific and Regulatory Consulting business of Cardinal Health Specialty Solutions (Beckloff Associates) will provide regulatory support to the National Institutes of Health’s (NIH) Therapeutics for Rare and Neglected Diseases (TRND) program ...
read more
Thursday, February 07, 2013
Metrics Inc. has appointed Joseph E. “Joe” Cobb Jr., CPIP, as director of pharmaceutical development.
read more
Monday, February 11, 2013
AMRI announced today that it has signed an exclusive license agreement with Chai Therapeutics, LLC for the development of ALB 109564(a), AMRI’s novel tubulin inhibitor compound in late Phase I testing for the treatment of cancer. This agreement ...
read more
Monday, February 11, 2013
Ash Stevens Inc. (ASI), a full service contract pharmaceutical manufacturer, is in the final stages of completing a multi-year, multi-million dollar expansion to its cGMP manufacturing facility in Riverview, Michigan. All construction on the project ...
read more
Monday, February 11, 2013
Stuart Needleman, President and Chief Operating Officer, Aptuit LLC, announced the availability of GLP-qPCR Biodistribution Studies required as part of the preclinical development study package for application in First In Man (FIM) of Gene Therapy ...
read more